{"id":3674,"date":"2022-09-06T09:58:06","date_gmt":"2022-09-06T09:58:06","guid":{"rendered":"https:\/\/www.peregrinevc.com\/?p=3674"},"modified":"2022-10-19T13:47:10","modified_gmt":"2022-10-19T13:47:10","slug":"variantyx-secured-41-5m-in-series-c-funding-round","status":"publish","type":"post","link":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/","title":{"rendered":"Variantyx secured $41.5M in series C  funding round"},"content":{"rendered":"<p>The proprietary whole genome sequencing and analysis platforms created by Variantyx improve the understanding of individual patients&#8217; personal genetic composition and assist Healthcare professionals in providing an accurate diagnosis in addition to highly personalized treatments.&nbsp;<\/p>\n<p>The company\u2019s solutions are currently meant for use in several medical fields, including rare genetic disorders, reproductive health, and precision oncology. Variantyx&#8217;s cutting-edge precision oncology solution is meant to analyze and map the unique genetic alterations in a patient\u2019s cancerous tumor to help predict the response to various therapies and recommend the most effective course of medical treatment.<\/p>\n<p style=\"margin-bottom: 0px;\"><a href=\"https:\/\/www.prnewswire.com\/news-releases\/technology-driven-precision-medicine-company-variantyx-secures-41-5m-in-funding-301480542.html\" target=\"_blank\" rel=\"noopener\">You can read more here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The proprietary whole genome sequencing and analysis platforms created by Variantyx improve the understanding of individual patients&#8217; personal genetic composition and assist Healthcare professionals in providing an accurate diagnosis in addition to highly personalized treatments.&nbsp; The company\u2019s solutions are currently meant for use in several medical fields, including rare genetic disorders, reproductive health, and precision [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4238,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-3674","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Variantyx secured $41.5M in series C funding round - Peregrine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Variantyx secured $41.5M in series C funding round - Peregrine\" \/>\n<meta property=\"og:description\" content=\"The proprietary whole genome sequencing and analysis platforms created by Variantyx improve the understanding of individual patients&#8217; personal genetic composition and assist Healthcare professionals in providing an accurate diagnosis in addition to highly personalized treatments.&nbsp; The company\u2019s solutions are currently meant for use in several medical fields, including rare genetic disorders, reproductive health, and precision [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Peregrine\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-06T09:58:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-19T13:47:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Amit Alfasi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amit Alfasi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/\"},\"author\":{\"name\":\"Amit Alfasi\",\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521\"},\"headline\":\"Variantyx secured $41.5M in series C funding round\",\"datePublished\":\"2022-09-06T09:58:06+00:00\",\"dateModified\":\"2022-10-19T13:47:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/\"},\"wordCount\":110,\"publisher\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/\",\"url\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/\",\"name\":\"Variantyx secured $41.5M in series C funding round - Peregrine\",\"isPartOf\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg\",\"datePublished\":\"2022-09-06T09:58:06+00:00\",\"dateModified\":\"2022-10-19T13:47:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage\",\"url\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg\",\"contentUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg\",\"width\":800,\"height\":400,\"caption\":\"Variantyx\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.peregrinevc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Variantyx secured $41.5M in series C funding round\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.peregrinevc.com\/#website\",\"url\":\"https:\/\/www.peregrinevc.com\/\",\"name\":\"Peregrine\",\"description\":\"Venture Capital Fund\",\"publisher\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.peregrinevc.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.peregrinevc.com\/#organization\",\"name\":\"PEREGRINE VENTURES\",\"url\":\"https:\/\/www.peregrinevc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg\",\"contentUrl\":\"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg\",\"width\":1,\"height\":1,\"caption\":\"PEREGRINE VENTURES\"},\"image\":{\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521\",\"name\":\"Amit Alfasi\",\"url\":\"https:\/\/www.peregrinevc.com\/author\/amit\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Variantyx secured $41.5M in series C funding round - Peregrine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/","og_locale":"en_US","og_type":"article","og_title":"Variantyx secured $41.5M in series C funding round - Peregrine","og_description":"The proprietary whole genome sequencing and analysis platforms created by Variantyx improve the understanding of individual patients&#8217; personal genetic composition and assist Healthcare professionals in providing an accurate diagnosis in addition to highly personalized treatments.&nbsp; The company\u2019s solutions are currently meant for use in several medical fields, including rare genetic disorders, reproductive health, and precision [&hellip;]","og_url":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/","og_site_name":"Peregrine","article_published_time":"2022-09-06T09:58:06+00:00","article_modified_time":"2022-10-19T13:47:10+00:00","og_image":[{"width":800,"height":400,"url":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg","type":"image\/jpeg"}],"author":"Amit Alfasi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Amit Alfasi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#article","isPartOf":{"@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/"},"author":{"name":"Amit Alfasi","@id":"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521"},"headline":"Variantyx secured $41.5M in series C funding round","datePublished":"2022-09-06T09:58:06+00:00","dateModified":"2022-10-19T13:47:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/"},"wordCount":110,"publisher":{"@id":"https:\/\/www.peregrinevc.com\/#organization"},"image":{"@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage"},"thumbnailUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/","url":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/","name":"Variantyx secured $41.5M in series C funding round - Peregrine","isPartOf":{"@id":"https:\/\/www.peregrinevc.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage"},"image":{"@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage"},"thumbnailUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg","datePublished":"2022-09-06T09:58:06+00:00","dateModified":"2022-10-19T13:47:10+00:00","breadcrumb":{"@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#primaryimage","url":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg","contentUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/09\/Neerman-Num-7.jpg","width":800,"height":400,"caption":"Variantyx"},{"@type":"BreadcrumbList","@id":"https:\/\/www.peregrinevc.com\/news\/variantyx-secured-41-5m-in-series-c-funding-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.peregrinevc.com\/"},{"@type":"ListItem","position":2,"name":"Variantyx secured $41.5M in series C funding round"}]},{"@type":"WebSite","@id":"https:\/\/www.peregrinevc.com\/#website","url":"https:\/\/www.peregrinevc.com\/","name":"Peregrine","description":"Venture Capital Fund","publisher":{"@id":"https:\/\/www.peregrinevc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.peregrinevc.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.peregrinevc.com\/#organization","name":"PEREGRINE VENTURES","url":"https:\/\/www.peregrinevc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg","contentUrl":"https:\/\/www.peregrinevc.com\/wp-content\/uploads\/2022\/02\/logo.svg","width":1,"height":1,"caption":"PEREGRINE VENTURES"},"image":{"@id":"https:\/\/www.peregrinevc.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.peregrinevc.com\/#\/schema\/person\/7cf18986a83be1600a6ceecb2f6ed521","name":"Amit Alfasi","url":"https:\/\/www.peregrinevc.com\/author\/amit\/"}]}},"_links":{"self":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts\/3674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/comments?post=3674"}],"version-history":[{"count":5,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts\/3674\/revisions"}],"predecessor-version":[{"id":3680,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/posts\/3674\/revisions\/3680"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/media\/4238"}],"wp:attachment":[{"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/media?parent=3674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/categories?post=3674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.peregrinevc.com\/wp-json\/wp\/v2\/tags?post=3674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}